{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T10:31:45Z","timestamp":1787653905165,"version":"build-2736575974"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s12664-025-01856-7","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:59:09Z","timestamp":1759985949000},"page":"872-883","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oral semaglutide for weight loss and liver fibrosis in overweight and obesity: A randomized controlled trial"],"prefix":"10.1007","volume":"45","author":[{"given":"Anudeep","family":"Katrevula","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3203-7708","authenticated-orcid":false,"given":"Rakesh","family":"Kalapala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddhant","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Jagtap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Chhabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand V.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandhana","family":"Merugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goutham Reddy","family":"Katukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageshwar Reddy","family":"Duvvur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"key":"1856_CR1","unstructured":"Lobstein T, Brinsden H, Neveux M. World Obesity Atlas. London: World Obesity Federation; 2022. Available from: https:\/\/www.worldobesity.org\/resources\/resource-library\/world-obesity-atlas-2022."},{"key":"1856_CR2","doi-asserted-by":"publisher","unstructured":"GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377:13\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1614362.","DOI":"10.1056\/NEJMoa1614362"},{"issue":"4","key":"1856_CR3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.7861\/clinmed.2023-0168","volume":"23","author":"B Masood","year":"2023","unstructured":"Masood B, Moorthy M. Causes of obesity: a review. Clin Med. 2023;23:284\u201391.","journal-title":"Clin Med"},{"issue":"7","key":"1856_CR4","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2337\/dc10-2415","volume":"34","author":"RR Wing","year":"2011","unstructured":"Wing RR, Lang W, Wadden TA, et al. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care. 2011;34:1481\u20136.","journal-title":"Diabetes Care"},{"key":"1856_CR5","doi-asserted-by":"publisher","unstructured":"Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022;18:1345\u201356. https:\/\/doi.org\/10.1016\/j.soard.2022.08.013.","DOI":"10.1016\/j.soard.2022.08.013"},{"issue":"5","key":"1856_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","volume":"163","author":"E Grunvald","year":"2022","unstructured":"Grunvald E, Shah R, Hernaez R, et al. AGA clinical practice guideline on pharmacological interventions for adults with obesity. Gastroenterology. 2022;163:1198\u2013225.","journal-title":"Gastroenterology"},{"issue":"1","key":"1856_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/dom.14863","volume":"25","author":"NC Bergmann","year":"2023","unstructured":"Bergmann NC, Davies MJ, Lingvay I, Knop FK. Semaglutide for the treatment of overweight and obesity: a review. Diabetes Obes Metab. 2023;25:18\u201335.","journal-title":"Diabetes Obes Metab"},{"issue":"15","key":"1856_CR8","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jama.2017.14752","volume":"318","author":"M Davies","year":"2017","unstructured":"Davies M, Pieber TR, Hartoft-Nielsen ML, et al. Effect of oral semaglutide compared with placebo and subcutaneous semaglutide on glycemic control in patients with type 2 diabetes: a randomized clinical trial. JAMA. 2017;318:1460\u201370.","journal-title":"JAMA"},{"issue":"11","key":"1856_CR9","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1056\/NEJMoa2032183","volume":"384","author":"JP Wilding","year":"2021","unstructured":"Wilding JP, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989\u20131002.","journal-title":"N Engl J Med"},{"issue":"10403","key":"1856_CR10","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0140-6736(23)01185-6","volume":"402","author":"FK Knop","year":"2023","unstructured":"Knop FK, Aroda VR, do Vale RD, et al. Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2023;402:705\u201319.","journal-title":"Lancet"},{"key":"1856_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cegh.2023.101316","volume":"22","author":"A Awasthi","year":"2023","unstructured":"Awasthi A, Panduranga AB, Deshpande A. Prevalence of overweight and obesity in South Asia: a regional perspective. Clin Epidemiol Glob Health. 2023;22: 101316.","journal-title":"Clin Epidemiol Glob Health"},{"key":"1856_CR12","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13679-020-00422-w","volume":"10","author":"YJ Tak","year":"2021","unstructured":"Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021;10:14\u201330.","journal-title":"Curr Obes Rep"},{"key":"1856_CR13","first-page":"1","volume":"13","author":"DH Ryan","year":"2024","unstructured":"Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nat Med. 2024;13:1\u20139.","journal-title":"Nat Med"},{"issue":"11","key":"1856_CR14","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","volume":"12","author":"CM Prado","year":"2024","unstructured":"Prado CM, Phillips SM, Gonzalez MC, Heymsfield SB. Muscle matters: the effects of medically induced weight loss on skeletal muscle. Lancet Diabetes Endocrinol. 2024;12:785\u20137.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"1856_CR15","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.2000.89.1.81","author":"I Janssen","year":"2000","unstructured":"Janssen I, Heymsfield SB, Wang Z, Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18\u201388 yr. J Appl Physiol (1985). 2000;89:81-8.\u00a0https:\/\/doi.org\/10.1152\/jappl.2000.89.1.81.","journal-title":"J Appl Physiol"},{"issue":"1","key":"1856_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jama.2024.6586","volume":"332","author":"C Conte","year":"2024","unstructured":"Conte C, Hall KD, Klein S. Is weight loss\u2013induced muscle mass loss clinically relevant? JAMA. 2024;332:9\u201310.","journal-title":"JAMA"},{"issue":"4","key":"1856_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/nu10040423","volume":"10","author":"AV Sardeli","year":"2018","unstructured":"Sardeli AV, Komatsu TR, Mori MA, G\u00e1spari AF, Chacon-Mikahil MP. Resistance training prevents muscle loss induced by caloric restriction in obese elderly individuals: a systematic review and meta-analysis. Nutrients. 2018;10: 423.","journal-title":"Nutrients"},{"key":"1856_CR18","doi-asserted-by":"crossref","unstructured":"Mechanick JI, Butsch WS, Christensen SM, et al. Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity. Obes Rev. 2025;26: e13841.","DOI":"10.1111\/obr.13841"},{"issue":"8","key":"1856_CR19","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1111\/dom.14725","volume":"24","author":"JP Wilding","year":"2022","unstructured":"Wilding JP, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022;24:1553\u201364.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"1856_CR20","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/dom.15400","volume":"26","author":"T Yates","year":"2024","unstructured":"Yates T, Biddle GJ, Henson J, et al. Impact of weight loss and weight gain trajectories on body composition in a population at high risk of type 2 diabetes: a prospective cohort analysis. Diabetes Obes Metab. 2024;26:1008\u201315.","journal-title":"Diabetes Obes Metab"},{"key":"1856_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102475","author":"SB Jensen","year":"2024","unstructured":"Jensen SB, Blond MB, Sandsdal RM, et al. Healthy weight loss maintenance with exercise, GLP-1 receptor agonist, or both combined followed by one year without treatment: a post-treatment analysis of a randomised placebo-controlled trial.\u00a0EClinicalMedicine. 2024;69:102475.\u00a0https:\/\/doi.org\/10.1016\/j.eclinm.2024.102475.","journal-title":"EClinicalMedicine"}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-025-01856-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-025-01856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T09:42:35Z","timestamp":1787132555000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-025-01856-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1856"],"URL":"https:\/\/doi.org\/10.1007\/s12664-025-01856-7","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"7 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AK, RK, SA, NJ, PC, AVK, CM, GRK and NRD declare no conflict of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.","order":2,"name":"Ethics","label":"Ethics statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed written consent for the publication of study data was obtained from all participants.","order":3,"name":"Ethics","label":"Patient Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ClinicalTrials.gov Identifier: NCT05442450.","order":4,"name":"Ethics","label":"Clinical trial registry number","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of AIG Hospitals (IRB No: AIG\/IEC-BH&R 27\/05.2022\u201303, Approval Date: 28th May 2022).","order":5,"name":"Ethics","label":"IRB approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology\u00a0or the printer\/publishers are responsible for the results\/findings and content of this article.","order":6,"name":"Ethics","label":"Disclaimer","group":{"name":"EthicsHeading","label":"Declarations"}}]}}